Abstracts presented during the WIN Consortium 2024 in Abu Dhabi are now published - Humaid Al-Shamsi
Burjeel Holdings Khaled Musallam MD PhD Wafik S. El-Deiry, MD, PhD, FACP Razelle Kurzrock, MD Catherine Bresson
oncodaily.com/70885.html

#Cancer #Immunotherapy #OncoDaily #Oncology #WINSymposium

🎙️Diwakar Davar, M.D. & Jason Luke, MD, FACP of UPMC Hillman Cancer Center discuss newly released data from #ASCO24 that could shape the future of #immunotherapy in #melanoma and beyond on the #ASCODailyNews Podcast: brnw.ch/21wK8vb #melsm #OncTwitter

Great questions from Shanda Blackmon, MD covering a range of esophageal cancer questions including optimal groups for perioperative immunotherapy and operative techniques. ESTS
#ESTS2024

Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC - Marc Machaalani
Nazli Dizman Emre Yekedüz Toni Choueiri, MD Dana-Farber Lank Center for Genitourinary Oncology ASCO
oncodaily.com/70596.html

#ASCO #Cancer #Immunotherapy #DanaFarberCancerInstitute #MRCC #OncoDaily #Oncology

May’s Melanoma awareness month & this is my Melanoma scar. What you can’t see are 2 tumours I developed internally which led to stage 4 incurable cancer diagnosis, but thankfully Immunotherapy is keeping that under control. Please look after your skin, it’s your largest organ.

#HCC #systemictherapy #locoregionaltherapy
📢Topic: Issue on combined locoregional and systemic treatment for hepatocellular carcinoma
📒Read more: oaepublish.com/articles/2394-…
✅RFA and molecular targeting agents
✅RFA and immunotherapy
✅SIRT/TARE and systemic therapy

مشاركة طلاب الوحدة بتسعة ملصقات علمية من احدث ابحاثنا في المؤتمر الدولي الأول للتشخيص والطب والمخبري بـ #تجمع_مكة_المكرمة_الصحي تحت عنوان «التشخيص والطب المخبري» في مدينة جدة
Saudi Society for Molecular Biology & Biotech
الجمعية السعودية للطب المخبري
جامعة الملك عبدالعزيز
KFMRC
#SSLM2024
يتبع

#ASCO24 - While we peruse abstracts, take the time to bookmark education sessions
🔖 'Integrating Immunotherapy Into Early-Stage Lung Cancer'
📍Jun 2, Hall B1, 945 CDT
Drs. Jamie Chaft, Goulart, Dziadziuszko ASCO #LCSM

Thank you to Evan Hall and Dr. Byrd for the opportunity to present the work going on in the Jennifer Wargo MD lab - Y. David Seo MD
MD Anderson Cancer Center Fred Hutchinson Cancer Center Melanoma Research Foundation
oncodaily.com/68294.html

#Cancer #Cancer Treatment #Immunotherapy #MelanomaResearch #OncoDaily #Oncology

SITC will host the free Summit on Immunomodulation of ADCs
Society for Immunotherapy of Cancer @tlowinger Mersana Therapeutics Dana-Farber Alfred Zippelius University of Basel
oncodaily.com/69674.html

#Cancer #Immunotherapy #Cancer Research #Cancer Treatment #OncoDaily #Oncology #SITC

“We're still a long way from #immunotherapy curing #cancer without side effects in 100% of patients, but some patients are getting long, durable responses that would have been impossible in the past.' Dr. Mario Sznol
yalemedicine.org/news/how-immun…
Yale Cancer Center Yale School of Medicine Yale New Haven Hosp

Check out the state of immunotherapy in resectable NSCLC: This ASCO Ed Book article includes views from academia & FDA. Good warmup for #ASCO24 Education Session “Integrating Immunotherapy into Early-Stage Lung Cancer' on June 2. 🧵 1/2
ascopubs.org/doi/10.1200/ED…
#OCEPublications

To improve cancer treatment, BRC researchers are using innovative organ-on-a-chip technology to imitate the liver’s environment and improve immunotherapy for #LiverCancer .

Read more: birminghambrc.nihr.ac.uk/news-and-event…

#OrganOnAChip #LiverTwitter

The James P. Allison Institute’s Immunotherapy Platform is again up and running in the tmc3 collaborative building. The IMT performs and array of immune monitoring assays on patient tissues in collaboration with MD Anderson researchers and alliance partners.

📢✨Exciting news! We at #OncoDaily are launching a comprehensive series of articles on Cancer Immunotherapy, bringing the most up-to-date, evidence-based information to patients and caregivers.

We would also welcome input from oncologists and other healthcare professionals.

We’re proud to share Dr. Joseph Grossman’s perspective of our investigational immunotherapy pipeline - Agenus Inc. ($AGEN)
oncodaily.com/69872.html

#Cancer #OncoDaily #Oncology #Immunotherapy

BIG DEAL for those living with small cell lung cancer - Dr. Amy C. Moore
LUNGevity Foundation
oncodaily.com/67880.html

#Cancer #Cancer Research #SCLC #FDA #Immunotherapy #LUNGevityFoundation #OncoDaily #Oncology

$SLS Lead drug, Galinpepimut-S, is a WT1-targeted cancer immunotherapy which was created at Memorial Sloan Kettering Cancer Center. With six 'cancer vaccines' already FDA approved and available, GPS seeks to add to a burgeoning modality for improving the lives of cancer patients.